B. Braun
The Company
B. Braun is one of the world’s leading medical technology companies, developing medical devices, pharmaceutical products, and healthcare solutions that help healthcare professionals deliver safe, effective, and efficient patient care.
With operations in more than 60 countries, B. Braun offers a broad portfolio of products spanning infusion therapy, surgery, orthopedics, pain management, dialysis, vascular access, and infection prevention, making it one of the largest and most diversified suppliers to the global healthcare industry.
At a Glance
3
Data pools (atrify, GHX and NPC)
<8 months
GUDID implementation timeline
>85%
Cost savings per market
The Challenge
B. Braun needed to support a growing global business across more than 60 countries while managing an expanding portfolio of healthcare products. This required a consistent approach to maintaining, validating, and publishing trusted product information to meet both regulatory and commercial requirements.
In addition to complying with the FDA’s Unique Device Identification (UDI) regulations, B. Braun needed to synchronize standardized product information with trading partners through multiple GDSN data pools, including atrify, GHX, and the National Product Catalogue (NPC).
The company faced several challenges:
- Product data was not consistently synchronized with regulatory agencies and trading partners.
- Product information lacked standardized governance across global markets.
- Publishing and maintaining product data required significant manual effort.
- Multiple regional requirements increased the complexity and cost of expanding into new markets.
“We were at risk to miss the UDI Class II deadline of September 2016 and our team in Australia suggested Innovit. After an extensive RFP process involving numerous solutions, the path forward was clear.”
The Solution
Following an extensive evaluation process, B. Braun selected Innovit’s cloud-based UDI and GDSN solutions to establish a standardized platform for regulatory submissions and global product data syndication.
Key requirements included:
- A flexible and extensible product data model
- Certified GDSN connectivity supporting multiple data pools
- Native FDA GUDID connectivity
- Built-in data validation and reporting capabilities
- Rapid implementation to meet FDA UDI compliance deadlines
Innovit’s solution was integrated with B. Braun’s internal systems, providing a unified global process for managing regulatory and GDSN publication activities across multiple markets.
The Results
Within eight months of project kickoff, B. Braun successfully implemented the solution and began submitting UDI data to FDA’s GUDID, meeting critical regulatory deadlines. The implementation was subsequently extended to support product data publication through multiple GDSN data pools, including atrify, GHX, and NPC.
The solution was deployed across the United States, Canada, the United Kingdom, the Netherlands, Australia, and New Zealand, with the goal of adding remaining markets in France, Germany, Italy, Spain and Switzerland shortly after.
By establishing a reusable template for global product data syndication, B. Braun significantly reduced the effort and cost required to onboard new markets. Standardized data validation, transformation, and publication processes enabled efficient regulatory submissions and GDSN data syndication, while eliminating the need for market-specific customization and expensive consulting services.
“We expanded to the UK and Netherlands market at fraction of cost when compared to our initial efforts in America and Canada, resulting in a net savings of more than 85% per market.
Innovit helped us overcome so many challenges by allowing us to implement a global system and unified process that’s fully integrated with our internal systems.”
